Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.45 CHF | -0.36% | -1.54% | -3.04% |
Feb. 16 | BB Biotech's Loss Narrows in FY23; Operating Income Down | MT |
Feb. 14 | BB Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 190M 208M | Sales 2025 * | 101M 110M | Capitalization | 2.27B 2.49B |
---|---|---|---|---|---|
Net income 2024 * | 152M 166M | Net income 2025 * | 72M 78.74M | EV / Sales 2024 * | 13.5 x |
Net Debt 2024 * | 291M 318M | Net Debt 2025 * | 324M 355M | EV / Sales 2025 * | 25.8 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
13.9
x | Employees | 10 |
Yield 2024 * |
5.67% | Yield 2025 * |
5.79% | Free-Float | 97.24% |
1 day | -0.36% | ||
1 week | -1.54% | ||
Current month | -9.00% | ||
1 month | -12.00% | ||
3 months | -5.80% | ||
6 months | +13.72% | ||
Current year | -3.04% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 41.45 | -0.36% | 57,148 |
24-04-23 | 41.6 | +0.97% | 113,601 |
24-04-22 | 41.2 | -0.48% | 63,519 |
24-04-19 | 41.4 | -0.84% | 62,131 |
24-04-18 | 41.75 | -0.83% | 61,488 |
Delayed Quote Swiss Exchange, April 24, 2024 at 11:31 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.04% | 2.49B | |
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- BION Stock